阅读说明：本技术 一种元宝枫油乳剂及其应用 (Acer truncatum oil emulsion and application thereof ) 是由 李岱龙 卢雪梅 王长勇 王文文 张强 孔贺 陈德诚 于 2020-12-15 设计创作，主要内容包括：本发明公开了一种元宝枫油乳剂及其应用。属于医药技术领域。包括以下原料：元宝枫油,低聚果糖,大豆卵磷脂,单甘酯,燕窝酸,余量为纯化水。本发明制备的乳剂中神经酸含量≥0.5％,其余指标符合GB19641-2015质量标准,其中,体积平均粒径60～100nm,pH值6～7,乳剂稳定时间≥1年,菌落总数cfu/100ml≤10000,大肠菌群cfu/100ml≤6,致病菌不得检出。本产品富含对人体神经系统发育有益的神经酸,并可促进人体消化吸收,长期使食用对老年人的睡眠质量、简易精神状态、Blessed行为量等均有明显改善。(The invention discloses an acer truncatum buge oil emulsion and application thereof. Belongs to the technical field of medicine. The method comprises the following raw materials: acer truncatum buge oil, fructo-oligosaccharide, soybean lecithin, monoglyceride, cubilose acid and the balance of purified water. The content of the nervonic acid in the emulsion prepared by the invention is more than or equal to 0.5 percent, and other indexes meet the GB19641-2015 quality standard, wherein the volume average particle size is 60-100 nm, the pH value is 6-7, the emulsion stabilization time is more than or equal to 1 year, the total number cfu/100ml of colonies is less than or equal to 10000, the cfu/100ml of coliform groups is less than or equal to 6, and pathogenic bacteria cannot be detected. The product is rich in nervonic acid beneficial to the development of human nervous system, can promote the digestion and absorption of human body, and obviously improves the sleep quality, simple mental state, Blessed behavior and the like of the old after long-term eating.)

1. The acer truncatum buge oil emulsion is characterized by comprising the following raw materials in parts by weight per 1000: 140-160 parts of acer truncatum buge oil, 10-15 parts of fructo-oligosaccharide, 20-30 parts of soybean lecithin, 20-30 parts of monoglyceride, 0.8-1.2 parts of cubilose acid and the balance of purified water.

2. The acer truncatum oil emulsion of claim 1, comprising the following raw materials in 1000 parts by weight: 150 parts of acer truncatum buge oil, 12 parts of fructo-oligosaccharide, 25 parts of soybean lecithin, 25 parts of monoglyceride, 1 part of cubilose acid and the balance of purified water.

3. The acer truncatum oil emulsion of claim 1 or 2, wherein the acer truncatum oil has a nervonic acid content of not less than 5.5%.

4. Use of the acer truncatum buge oil emulsion of any one of claims 1 to 3 in the preparation of a medicament for preventing and treating alzheimer's disease, cerebral apoplexy sequelae or senile dementia.

Technical Field

The invention relates to the technical field of medicines, in particular to an acer truncatum buge oil emulsion and application thereof.

Background

Alzheimer's disease (senile dementia) is a common degenerative disease of the central nervous system, and in recent years, the number of patients has increased, and causes and treatment systems of various chronic diseases, common diseases and frequently encountered diseases have close relationship with how to improve the self-absorption and utilization capacity of food of patients. About 40-50% of 1.4 hundred million hospitalized patients in China in 2009, namely 5600 to 7000 million patients need clinical nutrition diagnosis and treatment, but less than 200 million patients receiving clinical nutrition intervention and treatment and less than ten thousand patients receiving clinical nutrition system diagnosis.

However, China faces the problems that raw materials of food for improving the nervous system of a human body are scarce and the stability of the composite medical emulsion is poor in special medical food.

Therefore, the problem that needs to be solved by the technical personnel in the field is to provide the acer truncatum buge oil emulsion which has the characteristics of good stability and obvious improvement on the symptoms of patients.

Disclosure of Invention

In view of the above, the invention provides an acer truncatum buge oil emulsion and application thereof.

The invention takes the acer truncatum bunge (seed) oil rich in nervonic acid as the main raw material, and is refined by optimizing the raw materials and the process.

In order to achieve the purpose, the invention adopts the following technical scheme:

every 1000 parts by weight of acer truncatum oil emulsion comprises the following raw materials: 140-160 parts of acer truncatum buge oil, 10-15 parts of fructo-oligosaccharide, 20-30 parts of soybean lecithin, 20-30 parts of monoglyceride, 0.8-1.2 parts of cubilose acid and the balance of purified water.

Preferably: 150 parts of acer truncatum buge oil, 12 parts of fructo-oligosaccharide, 25 parts of soybean lecithin, 25 parts of monoglyceride, 1 part of cubilose acid and the balance of purified water.

Has the advantages that: by adopting the proportioning relation of the raw materials, the average particle size such as the volume, the length, the area and the like of the emulsion is better after homogenization; if the amount of raw materials is greatly increased, the physical and chemical indexes of the emulsion are affected.

Preferably: the content of nervonic acid in the acer truncatum buge oil is more than or equal to 5.5 percent.

Namely, the nervonic acid content is more than or equal to 5.5g in every 100g of acer truncatum buge oil.

Furthermore, the nervonic acid content in the acer truncatum buge oil emulsion is more than or equal to 0.5 percent.

Namely, the nervonic acid content is more than or equal to 0.5g per 100g of the emulsion.

Has the advantages that: the raw materials are reasonably matched, the fatty acid composition of the acer truncatum oil is between that of peanut oil and rapeseed oil, the content of unsaturated fatty acid reaches 90 percent, the content of essential fatty acid (linoleic acid) is higher than that of imported olive oil and palm oil, and the acer truncatum oil is rich in various nutrients and trace elements and especially contains nervonic acid.

Nervonic acid is a neurotrophic factor, and the eating of nervonic acid can obviously improve the memory capacity of human bodies and has obvious curative effect on the development and growth of the cranial nerve system.

Functional tests prove that the health food has better effects of improving memory, delaying senility, regulating blood fat and resisting fatigue after being eaten, and the average effective rate is more than 99.6 percent. The optimized medical emulsion with small particle size PDI value is obtained.

The invention also provides application of the acer truncatum oil emulsion in preparing a medicament for preventing and treating Alzheimer disease, cerebral apoplexy sequelae or senile dementia.

According to the technical scheme, compared with the prior art, the acer truncatum buge oil emulsion and the application thereof are disclosed, the acer truncatum buge oil emulsion is a composite emulsion and is subjected to high-pressure homogenizing and emulsifying to obtain the following technical effects: the volume average particle size is 60-100 nm, the nano-level is achieved, the pH value is 6-7, the emulsion stabilization time is more than or equal to 1 year, the total number cfu/100ml of colonies is less than or equal to 10000, the cfu/100ml of coliform is less than or equal to 6, and pathogenic bacteria are not detected. The food is rich in nervonic acid beneficial to the development of human nervous system, can promote the digestion and absorption of human body, and can obviously improve the sleep quality, simple mental state, Blessed behavior and the like of the old after long-term eating.

Drawings

In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the provided drawings without creative efforts.

FIG. 1 is a schematic diagram of a sample detection without homogenization treatment, in which the particle size is plotted as abscissa and the percentage is plotted as ordinate, and the points of each fraction percentage are connected to form a smooth frequency curve with undulated shape; particle size distribution: D10-D90 refer to the number of mean particle diameters (. mu.m) at which the corresponding cumulative percentage distributions reach the corresponding percentage values.

Fig. 2 is a schematic diagram of homogeneous detection of an acer truncatum oil emulsion sample provided by the invention, wherein the particle size is a horizontal coordinate, the percentage content is a vertical coordinate, and corresponding points are drawn according to the percentage content of each particle size and then connected with the points of the percentage content of each particle size to form a wavy smooth frequency curve; particle size distribution: D10-D90 refer to the number of mean particle diameters (. mu.m) at which the corresponding cumulative percentage distributions reach the corresponding percentage values.

Detailed Description

The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

The embodiment of the invention discloses acer truncatum buge oil emulsion and application thereof.

The raw materials required in the examples are all available from commercial sources, and the brand of the source is not limited.

The production process equipment and quality control equipment required for the examples are conventional commercially available equipment, for example, homogenizer equipment and systems purchased from AH22-100 high pressure homogenizer supplied by pharmaceutical equipment suppliers under the SEEKER industries, canada; the detection equipment is a Bettersize 2600 laser particle size distribution instrument; the quality inspection method is carried out according to the national regulation, such as the GB19641-2015 quality standard.

And will not be described in detail herein.

Example 1

Every 1000g of acer truncatum oil emulsion comprises the following raw materials: 140g of acer truncatum buge oil, 12g of fructo-oligosaccharide, 30g of soybean lecithin, 20g of monoglyceride, 1.2g of cubilose acid and the balance of purified water.

The preparation method comprises the following steps:

(1) heating 500g of purified water to 69 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1000r/min for 20min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 39 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1100r/min, and the shearing is carried out for 10min to obtain a primary suspension B;

(3) and adding 296.8g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 600bar, the homogenization time is 10min, and the process is repeated once; the third homogenization pressure was 1200bar and the time was 10 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Example 2

Every 1000 parts by weight of acer truncatum oil emulsion comprises the following raw materials: 150g of acer truncatum buge oil, 12g of fructo-oligosaccharide and 25g of soybean lecithin. 25g of monoglyceride, 1g of cubilose acid and the balance of purified water.

(1) Heating 500g of purified water to 70 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1000r/min for 25min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 40 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1100r/min, and the shearing is carried out for 20min to obtain a primary suspension B;

(3) and adding 287g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 600bar, the homogenization time is 10min, and the process is repeated once; the third homogenization pressure was 1200bar and the time was 10 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Example 3

Every 1000g of acer truncatum oil emulsion comprises the following raw materials: 160g of acer truncatum buge oil, 10g of fructo-oligosaccharide, 20g of soybean lecithin, 30g of monoglyceride, 0.8g of cubilose acid and the balance of purified water.

(1) Heating 500g of purified water to 71 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1100r/min for 20min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 41 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1000r/min, and the shearing is carried out for 15min, so as to obtain a primary suspension B;

(3) and adding 279.2g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 600bar, the homogenization time is 20min, and the process is repeated once; the third homogenization pressure was 1200bar and the time was 20 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Comparative example 1

Every 1000g of acer truncatum oil emulsion comprises the following raw materials: 140g of acer truncatum buge oil, 12g of fructo-oligosaccharide, 30g of soybean lecithin, 20g of monoglyceride, 1.2g of cubilose acid and the balance of purified water.

The preparation method comprises the following steps:

(1) heating 500g of purified water to 60 ℃, adding acer truncatum seed oil, fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1000r/min for 20min, and mixing uniformly to obtain a solution A;

(2) after the water of the liquid A is cooled to 39 ℃, high-speed shearing and homogenization are carried out; wherein the rotating speed of the shearing machine is 1100r/min, and the shearing is carried out for 10min to obtain a primary suspension B;

(3) and adding 296.8g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 600bar, the homogenization time is 10min, and the process is repeated once; the third homogenization pressure was 1200bar and the time was 10 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Comparative example 2

Every 1000 parts by weight of acer truncatum oil emulsion comprises the following raw materials: 150g of acer truncatum buge oil, 12g of fructo-oligosaccharide and 25g of soybean lecithin. 25g of monoglyceride, 1g of cubilose acid and the balance of purified water.

(1) Heating 500g of purified water to 70 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1000r/min for 25min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 40 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1100r/min, and the shearing is carried out for 20min to obtain a primary suspension B;

(3) and adding 287g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 500bar, the homogenization time is 12min, and the process is repeated once; the third homogenization pressure was 900bar and the time was 22 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Comparative example 3

Every 1000g of acer truncatum oil emulsion comprises the following raw materials: 160g of acer truncatum buge oil, 10g of fructo-oligosaccharide, 20g of soybean lecithin, 30g of monoglyceride, 0.8g of cubilose acid and the balance of purified water.

(1) Heating 500g of purified water to 71 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1100r/min for 20min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 41 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1000r/min, and the shearing is carried out for 15min, so as to obtain a primary suspension B;

(3) and adding 279.2g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenizing pressure is 600bar and homogenizing time is 20min, and the second homogenizing pressure is 1200bar and homogenizing time is 20 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Comparative example 4

Every 1000g of acer truncatum oil emulsion comprises the following raw materials: 140g of acer truncatum buge oil, 30g of fructo-oligosaccharide, 40g of soybean lecithin, 30g of monoglyceride, 2g of cubilose acid and the balance of purified water.

The preparation method comprises the following steps:

(1) heating 500g of purified water to 60 ℃, adding fructo-oligosaccharide, soybean lecithin and monoglyceride, stirring at 1000r/min for 20min, and uniformly mixing to obtain a solution A;

(2) adding Acer Truncatum Bunge oil when the solution A is cooled to 40 deg.C, and high-speed shearing and homogenizing; wherein the rotating speed of the shearing machine is 1100r/min, and the shearing is carried out for 10min to obtain a primary suspension B;

(3) and adding 258g of purified water into the primary suspension B, uniformly stirring, and carrying out high-pressure homogenizing emulsification through a high-pressure homogenizer: the first homogenization pressure is 600bar, the homogenization time is 10min, and the process is repeated once; the third homogenization pressure was 1200bar and the time was 10 min.

Wherein, the nervonic acid content of Acer Truncatum Bunge oil is not less than 5.5%.

Comparative example 5

The difference from example 1 is that all homogenization steps are omitted, the detection result is shown in FIG. 1, and the volume average diameter of 4.781 μm is not satisfactory and is not compared.

The experimental effect is as follows:

randomly sampling the emulsion prepared in the embodiment 1-3 for quality detection, wherein the quality detection standard refers to GB19641-2015 quality standard, and taking the embodiment 1 as an example, the randomly sampled sample has volume average particle size of 60-100 nm (as shown in figure 2), pH value of 6-7, emulsion stabilization time of more than or equal to 1 year, total number of colonies cfu/100ml of less than or equal to 10000, coliform group cfu/100ml of less than or equal to 6, pathogenic bacteria are not detected, and the nervonic acid content of the sample is more than or equal to 0.5 percent.

The sampling test results of examples 1 to 3 and comparative examples 1 to 4 are shown in Table 1:

TABLE 1

The results show that:

comparative example 1: compared with the example 1, the raw material formula is unchanged, and the main differences are as follows: the raw materials are not added twice or sheared in several times, but are added all at once in the step (1), so that the average particle sizes are different, and the effect is poor.

Comparative example 2: compared with the example 2, the raw material formula and the processes of the steps (1) and (2) are basically not changed, and the main difference is that: the homogenization pressure of the three times is reduced, the average grain diameter is different, and the effect is not good.

Comparative example 3: compared with the example 3, the raw material formula and the processes of the steps (1) and (2) are basically not changed, and the main difference is that: one-time homogenization process is reduced, the average particle size is different, and the effect is poor.

Comparative example 4: compared with the embodiment 1, the main differences are that: the raw material dosage is changed, the total proportion of fructo-oligosaccharide, monoglyceride and cubilose acid is improved, the process is basically not changed, and the average particle size is different, so that the effect is poor.

Example 4

Acer truncatum seed oil emulsions prepared in examples 1-3 were subjected to human trial tests and the statistical results (improved Barthel index rating scale) are shown in Table 2:

TABLE 2

Note:

the daily intake of each person is 100ml, and the person eats the food before dinner every day.

It is administered continuously for 3 months.

The results show that: the long-term eating of the health-care food can obviously improve the sleep quality, the simple mental state, the amount of the blanketed behaviors and the like of the old, particularly, after the health-care food is eaten for a period of time, the health-care food can automatically participate in self activities by depending on other people in the aspects of daily decoration, bathing, eating, using toilets, dressing, controlling urination and defecation, going up and down stairs and walking, and the mental state and the cognitive ability of the crowd are improved.

Example 6

Taking sleep case survey

Lu XX, female 53 years old, height: 167cm, body weight: 79.8kg, blood pressure: 137/76, blood sugar: 6.2, before taking, the sleeping memory and sleeping quality are poor, and the time for falling asleep every night is about 2 h. The actual sleeping time per night is 3-4 h. Insomnia and dreaminess, anxiety and forgetfulness. After taking Acer truncatum seed oil emulsion prepared in example 1 (100 ml/box and about 3ml each time) for one month, the time for falling asleep is improved to 0.5 h. The actual sleep increase was six hours per night. The number of easy waking times is 0 during the period, and the sleep quality is better. The memory is improved.

Lie XX, female 53 years old, height: 159cm, body weight: 61kg, blood pressure: 126/69, blood sugar: 4.6, the time for falling asleep before taking the medicine is about 1h, and the actual sleep per night is about 4 h. The sleep is easy to wake up 3-4 times per week, and the night is 3-4 times per week. The analgesic is administered 3-4 times per week. After taking Acer truncatum seed oil emulsion (100 ml/box and about 3ml each time) prepared in example 2 for one month, the time for falling asleep is improved to about 10min, the actual sleep per night is increased to 7h, and the sleep quality is obviously improved.

Yellow XX, male 66 years old, height: 172cm, body weight: 82kg, blood pressure: 136/82, the blood sugar meal has two hours of 10.6, the sleeping time of each night is 40min before taking, and the actual sleeping time of each night is about 3-4 hours. The number of awakening is 3-4 times per week, no medicine is taken in the period, and the time for falling asleep is improved to 10min after taking Acer truncatum Bunge seed oil emulsion (100 ml/box and about 3ml each time) prepared in example 3 for one month. The actual sleep is increased to about 7h every night. Sleep and memory are improved.

The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.

The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.